Previous Close | 2.2500 |
Open | 2.0000 |
Bid | 0.0500 |
Ask | 0.0900 |
Strike | 895.00 |
Expire Date | 2024-10-04 |
Day's Range | 0.1000 - 2.2800 |
Contract Range | N/A |
Volume | |
Open Interest | 251 |
ABBV lowers adjusted earnings guidance for 2024 from $10.71-$10.91 per share to $10.67-$10.87 to account for acquisition costs.
Viking Therapeutics stock is on the rise as the battle to develop new weight-loss drugs heats up. Here's what's at stake for the pharma giants fighting for position.
Stock picking is the hallmark of top mutual fund T. Rowe Price U.S. Equity Research Fund (PRCOX). But what makes this top stock mutual fund unique is that it's not the fund managers who pick the stocks that make it into the portfolio.